The relationship between opportunistic pulmonary fungal infections and cd4 count levels among hiv-seropositive patients in calabar, nigeria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 3, 2013, Pages 170-175

  Ogba, Ofonime M ^a   Abia Bassey, Lydia N ^a   Epoke, James ^a  

^a UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

CD4 counts; HIV AIDS; Infections; Mycoses; Opportunistic; Pulmonary

Indexed keywords

ABSIDIA; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS PATIENT; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA TROPICALIS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; COUGHING; CRYPTOCOCCUS NEOFORMANS; FEMALE; FEVER; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MICROSCOPY; MIXED INFECTION; NIGERIA; OPPORTUNISTIC INFECTION; PATIENT CARE; PICHIA GUILLIERMONDII; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECI; PREVALENCE; PROSPECTIVE STUDY; RHIZOPUS ARRHIZUS; SEROLOGY; SINUSITIS; SPUTUM ANALYSIS; THORAX PAIN; TUBERCULOSIS; WEIGHT REDUCTION; AIDS RELATED COMPLEX; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPOSITIVITY; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84880162363     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trs025     Document Type: Article

References (36)

1. Maplanka C. AIDS: Is there an answer to the global pandemic? The immune system in HIV infection and control. Viral Immunol 2007;20:331-42.
2. Shailaja LA, Pai LA, Mathur DR, Lakshmi V. Prevalence of bacterial and fungal agents causing lower respiratory tract infections in patients with HIV infection. Indian J Med Microbiol 2004;22:28-33.
3. United Nations General Assembly Special Session (UNGASS). Country Progress Report: Nigeria. Reporting Period: January 2008-December 2009. UNGASS; 2010. http://data.unaids.org/pub/Report/2010/nigeria_2010_country_progress_report_en.pdf [accessed 5 December 2012].
4. Martin EA, editor. Oxford Concise Medical Dictionary, 6th ed. Oxford: Oxford University Press; 2003. p. 488.
5. Ekong E, Uwah A, Grant I. Prevalence and types of opportunistic infections in HIV/AIDS patients in Nigeria. AIDS 2000;14(Suppl. 1):S84.
6. Mitchell TG. Medical mycology. In: Brooks GF, Butel JS, Morse SA, editors. Jawetz, Melnick and Adelberg's Medical Microbiology. Singapore: McGraw Hill; 2004; p. 645-51.
7. Owiredu WKB, Quaye L, Aminu N, Addai-Mensah O. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV patients and those on HAART. African Health Sci 2011;11:2-15.
8. Federal Ministry of Health. National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults. Abuja: FMH Press; 2007.
9. Wadhwa A, Kaur R, Agarwal SK et al. AIDS-related opportunistic mycoses seen in a tertiary care hospital in North India. J Med Microbiol 2007;56:1101-6.
10. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva: UNAIDS; 2010.
11. WHO/UNAIDS/UNICEF. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2010. Geneva: WHO HIV/AIDS Department; 2010.
12. National Agency for the Control of AIDS (NACA). National HIV/AIDS Strategic Framework (NHF) 2010-2015. Abuja: Society for Family Health; 2009.
13. WHO/UNAIDS/UNICEF. Global HIV/AIDS Response: Epidemic update And Health Sector Progress Towards Universal Access. Geneva: WHO HIV/AIDS Department; 2011.
14. Forbes BA, Sahm DF, Weissfeld AS. Laboratory methods in basic mycology. In: Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scott's Diagnostic Microbiology, 11th edition. St Louis: Mosby; 2005. pp. 711-871.
15. Koneman EW, Allen SD, Janda WM, et al. The role of microbiology laboratory in the diagnosis of infectious disease: Guidelines to practice and management, In: Pfeiffer RP, Magnus BC, editors. Color Atlas and Text Book of Diagnostic Microbiology. New York: Lippincot; 1997; p.69.
16. Cox GM, Mukherjee J, Cole GT, et al. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000;68:443-8.
17. Hoang LM, Maguire JA, Doyle P, et al. Cryptococcus neoformans infections in Vancouver Hospital and Health Sciences Centre (1997-2002): Epidemiology, microbiology and histopathology. J Med Microbiol 2004;53:935-40.
18. Kumari S, editor. Blood safety and clinical technology: Guidelines on standard operating procedures for laboratory diagnosis of HIV-opportunistic infections. New Dehli: WHO Regional Office for South East Asia: World Health Organisation; 2007.
19. Peters EJ, Essien OE, Immananagha KK, et al. CD4 Counts level and pattern of respiratory complications in HIV seropositive patients in Calabar, Nigeria. Niger J Physiol Sci 2007;22:93-7.
20. Kothari K, Goyal S. Clinical profile of AIDS. J Assoc Physicians India 2001;49:435-8.
21. Federal Ministry of Health. Department of Public Health. National Tuberculosis and Leprosy Control Program (NTBLCP). Workers' Manual 5th ed. Abuja: 2006; p.14-19.
22. Global HIV/AIDS Initiative Nigeria (GHAIN). Ghaining Ground quarterly report 2005:1-4.
23. Eza D, Cerrillo G, Moore DA. Postmortem findings and opportunistic infections in HIV positive patients from a public hospital in Peru. Pathol Res Prac 2006;202:767-75.
24. Diaz-Fuentes G, Shin C, Sy ER, et al. Pulmonary fungal involvement in HIV-positive patients in an inner city hospital in New York. Internet J Pulmonary Med 2007;7:DOI:.
25. Aluyi HSA, Otajevwo FD, Iweriebor O. Incidence of pulmonary mycoses in patients with acquired immunodeficiency diseases. Niger J Clin Prac 2010;13:78-83.
26. St-Germain G, Laverdiere M, Pelletier R. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2-year (1996-1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001;39:949-53.
27. Nissapatorn V, Lee C, Fatt QK, Abdullah KA. AIDS-related opportunistic infections in hospital Kuala Lumpur. Jpn J Infect Dis 2003;56:187-92.
28. Udwadia ZF, Doshi AV, Bhaduri AS. Pneumocystis carinii pneumonia in HIV infected patients from Mumbai. J Assoc Physicians India 2005;53:437-440.
29. Singh NS, Husain MD, Gayowski T, Cacciarelli TV. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant. Medicine 2004;83:188-92.
30. Chakaya JM, Bii C, Ng'ang'a L, et al. Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr Med J 2003;80:30-5.
31. Tchamran M. Bacterial lung disease from common bacteria during HIV infection in African adults hospitalized in Abidjan, Co^te d'Ivoire. Bull Soc Pathol Exot 1997;190:370-2 [in French].
32. Mitsunaga TM, Powel AM, Heard NJ, Larsen UM. Extramarital sex among Nigerian men, polygamy and other risk factors. J Acquir Immune Defic Syndr 2005;39:478-88.
33. Anon. CD4: The bar is raised. Africa Health 2010;322:19-22.
34. Njoku MO, Sirisena ND, Idoko JA, Jelpe D. CD4 Lymphocyte count in patients with HIV/AIDS and healthy population. Postgrad Med J 2003;10:135.
35. Bravo IM, Correnti M, Escalona L, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal 2006;11:E33-9.
36. Burns DN, Hillman D, Nearton JD. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:374-83.